Department of the air force family advocacy program: Exploring the impact of an antiviolence intervention program for women

Abstract: This mixed-methods study explores the impact of the Vista curriculum, a trauma-informed antiviolence intervention program for women who have used force in their intimate relationships, delivered by the Department of the Air Force Family Advocacy Program clinicians. Questions sought to understand any changes in personal growth, self-awareness, beliefs, and relationship interaction skills for 62 cisgender women. Findings suggest that women gained personal growth, self-awareness, and increased relationship tools. Women identified the positive impact cofacilitator support and non-judgment had on them and their ability to heal from their experiences and increase their awareness of viable non-forceful alternatives. Policy and practice implications are discussed.

Read the full article
Report a problem with this article

Related articles

  • More for Policy & Practice

    Temporal trends in opioid-related care and pain among Veterans at the end of life

    Abstract: Context: In response to the opioid crisis, federal guidelines were implemented, including the Veterans Health Administration's (VA) Opioid Safety Initiative in 2013. The impact of policies on patients near the end of life is unknown. Objective: Examine temporal trends in opioid prescribing, pain, and opioid overdoses among Veterans near the end of life. Methods: Retrospective, time series analysis of VA decedents between October 2009 and September 2018 whose next-of-kin participated in VA's Bereaved Family Survey (BFS). Using multivariate regression to adjust for sociodemographic and clinical covariates, we examined temporal trends in outpatient opioid prescribing, uncontrolled pain based on BFS report, and opioid overdose-related hospitalizations, in the last month of life, overall and by clinical diagnosis (cancer versus non-cancer). Results: Among 79,409 decedents, mean daily outpatient opioid dose in morphine milligram equivalents in the last month of life decreased from 4.6 mg in 2010 to 2.1 mg in 2018 (adjusted change -0.20 mg/year; P